The Latest Breaking News from Pfizer

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with COVID-19 from being hospitalized or dying, and it may even reduce the risk of developing long COVID. But the government plans to stop footing the bill…

Amid the stock market chaos due to the Fed’s fight against inflation and recessionary concerns, dividend stocks are gaining traction. Fundamentally strong dividend stocks can provide protection and ensure stable income. So, high-yield dividend stocks Pfizer (PFE), BHP Group (BHP), and Caledonia Mining (CMCL), with significant upside potential, might be…

Within months, the government plans to stop footing the bill — and millions of the uninsured and seniors might have to pay full price. Experts say that means fewer people will get the potentially life-saving treatments.

Andrew Bridgen described mRNA vaccines as ‘experimental’.

A coroner has found the contraceptive pill may have led to 17-year-old Isabella Alexander's death - and now her family are calling for changes to how it’s prescribed.

PHILADELPHIA — For years, scientists have tried, and failed, to make a one-and-done vaccine that would provide at least partial protection against all types of the flu.

Children between the age of six months and four years will receive a dose 10 times lower than that of the adult jab

Britain's health regulator has today authorised the Pfizer vaccine for infants as young as six months, as the decision opens the door for advisers to choose whether the jab should be given to under-fives

The move opens the door to vaccinating the country’s youngest children should the Joint Committee on Vaccination and Immunisation agree